ММВБ 3 197 1,3%  Nasdaq 9 389 0,3%  Биткойн 8 651 -0,6%  USD/RUB 61,5637 0,0% 
РТС 1 638 1,6%  S&P500 3 330 0,4%  Нефть 65,6 0,4%  EUR/RUB 68,1940 -0,2% 
Dow 29 348 0,2%  FTSE100 7 675 0,9%  EUR/USD 1,1096 0,1% 

Курс акций Abbott Laboratories [ISIN: US0028241000]

купить
продать

Abbott Laboratories - Профиль

Abbott Laboratories (Abbott) – основанная в 1888 году глобальная компания, работающая в сфере здравоохранения. Занимается производством оборудования для диагностики и лечения заболеваний, производством лечебного и детского питания и лекарств. Около 30% выручки приходится на США, 30% – на Западную Европу, Канаду, Японию и Австралию, 40% – развивающиеся рынки. В 2013 году завершила выделение исследовательского фармацевтического подразделения в отдельную фирму AbbVie.

Акционеры

Название Доля (%)
Freefloat99,24
Vanguard Group, Inc. (Subfiler)8,35
The Vanguard Group, Inc.8,05
Capital Research & Management Co. (Global Investors)6,40
State Street Corp.4,11
Vanguard Total Stock Market Index Fund2,81
Capital Research & Management Co. (International Investors)2,60
BlackRock Fund Advisors2,48
BlackRock Institutional Trust Co. NA2,40
Wellington Management Co. LLP2,30
American Funds Investment Company Of America2,04
Vanguard 500 Index Fund1,98
Massachusetts Financial Services Co.1,80
American Funds Growth Fund Of America1,74
Northern Trust Corp.1,49

Адрес

100 Abbott Park Road, 60064-6400 Abbott Park
а/я:
Телефон: +1 (224) 667-6100
Факс:
Вэб: http://www.abbott.com

Менеджмент

Miles D. White
Chairman & Chief Executive Officer
James E. Young
Chief Compliance & Ethics Officer, Vice President
Gene Huang
Chief Economist & Vice President
Brian Bernard Yoor
Chief Financial Officer & Executive VP-Finance
Darren W. McDew
Director
Michelle A. Kumbier
Director
Brian J. Blaser
Executive Vice President-Diagnostics Products
Daniel Gesua Sive Salvadori
Executive Vice President-Nutritional Products
John M. Capek
Executive Vice President-Ventures
Scott Brun
Head-Clinical Development
Samuel C. Scott
Independent Director
Glenn Fletcher Tilton
Independent Director
Robert J. Alpern
Independent Director
Sally E. Blount
Independent Director
Roxanne Schuh Austin
Independent Director
Edward Michael Liddy
Independent Director
Phebe N. Novakovic
Independent Director
Nancy McKinstry
Independent Director
John G. Stratton
Independent Director
Daniel J. Starks
Independent Director
William A. Osborn
Lead Independent Director
Jim Leffelman
Manager-Expense Reporting
Robert B. Ford
President & Chief Operating Officer
Hubert L. Allen
Secretary, Executive VP & General Counsel
Corlis D. Murray
Senior VP-Quality Assurance & Regulatory
Robert E. Funck
Senior Vice President, Head-Finance & Controller
Karen M. Peterson
Treasurer & Vice President
Kathryn S. Collins
Vice President-Commercial Legal Operations
Randel William Woodgrift
Vice President-Global Operations & Cardiovascular
David P. Mark
Vice President-Internal Audit
P. Claude Burcky
Vice President-International Government Affairs
Scott Leinenweber
Vice President-Investor Relations

Добавить или редактировать инструмент